QuiVad
My list

Home / United Kingdom / Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 6.51% on July 19, 2017. The shaded band matches the twelve months of the first chart.

November 1, 2012 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Hikma Pharmaceuticals PLC by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

266 disclosures on record for this share.
DateFund% of capitalEnd of publication
November 13, 2017Marshall Wace LLP1.22%
November 13, 2017Capital Fund Management SA0.81%
November 9, 2017Marshall Wace LLP1.15%
November 9, 2017Millennium International Management LP0.71%
November 3, 2017AQR Capital Management, LLC1.90%
November 1, 2017Jpmorgan Asset Management (UK) LTD0.71%
October 31, 2017AQR Capital Management, LLC1.88%
October 27, 2017Marshall Wace LLP1.01%
October 20, 2017Millennium International Management LP0.60%
October 17, 2017Marshall Wace LLP0.99%
October 12, 2017Marshall Wace LLP1.00%
October 11, 2017AKO Capital LLP FOR AKO Master Fund Limited0.51%
October 6, 2017Millennium International Management LP0.50%
October 2, 2017AQR Capital Management, LLC1.99%
September 29, 2017Marshall Wace LLP0.92%
September 26, 2017Capital Fund Management SA0.79%
September 21, 2017Marshall Wace LLP0.81%
September 21, 2017Capital Fund Management SA0.80%
September 18, 2017AKO Capital LLP FOR AKO Master Fund Limited0.48%
September 15, 2017AKO Capital LLP FOR AKO Master Fund Limited0.53%
September 5, 2017Blackrock Institutional Trust Company, National Association0.48%
September 4, 2017Marshall Wace LLP0.73%
August 31, 2017Marshall Wace LLP0.63%
August 31, 2017Blackrock Institutional Trust Company, National Association0.51%
August 29, 2017AKO Capital LLP FOR AKO Master Fund Limited0.60%
August 29, 2017Marshall Wace LLP0.53%
August 29, 2017AHL Partners LLP0.48%
August 17, 2017Marshall Wace LLP0.43%
August 16, 2017AHL Partners LLP0.51%
August 14, 2017Capital Fund Management SA0.70%
August 10, 2017AQR Capital Management, LLC2.01%
August 8, 2017Marshall Wace LLP0.50%
August 2, 2017Coatue Management, L.L.C.0.44%
August 1, 2017AQR Capital Management, LLC1.90%
August 1, 2017Capital Fund Management SA0.61%
July 31, 2017Pointstate Capital LP0.43%
July 28, 2017AKO Capital LLP FOR AKO Master Fund Limited0.70%
July 28, 2017Coatue Management, L.L.C.0.55%
July 25, 2017Coatue Management, L.L.C.0.67%
July 24, 2017Marshall Wace LLP0.48%
July 20, 2017Coatue Management, L.L.C.0.75%
July 19, 2017AQR Capital Management, LLC1.80%
July 12, 2017Marshall Wace LLP0.50%
July 10, 2017Capital Fund Management SA0.51%
July 4, 2017Millennium International Management LP0.49%
July 3, 2017AKO Capital LLP FOR AKO Master Fund Limited0.69%
June 30, 2017AQR Capital Management, LLC1.70%
June 28, 2017Millennium International Management LP0.59%
June 27, 2017Jpmorgan Asset Management (UK) LTD0.61%
June 23, 2017Millennium International Management LP0.60%

Download 266 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hikma Pharmaceuticals PLC, source FCA, data as at September 19, 2019, https://www.quivad.com/action/hikma-pharmaceuticals-plc?page=3